Leiter, Ulrike and Heppt, Markus and Steeb, Theresa and Amaral, Teresa and Bauer, Andrea and Becker, Juergen C. and Breitbart, Eckhardt and Breuninger, Helmut and Diepgen, Thomas and Dirschka, Thomas and Eigentler, Thomas and Flaig, Michael and Follmann, Markus and Fritz, Klaus and Greinert, Ruediger and Gutzmer, Ralf and Hillen, Uwe and Ihrler, Stephan and John, Swen Malte and Koelbl, Oliver and Kraywinkel, Klaus and Loeser, Christoph and Nashan, Dorothee and Noor, Seema and Nothacker, Monika and Pfannenberg, Christina and Salavastru, Carmen and Schmitz, Lutz and Stockfleth, Eggert and Szeimies, Rolf-Markus and Ulrich, Claas and Welzel, Julia and Wermker, Kai and Garbe, Claus and Berking, Carola (2020) S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 18 (4). pp. 400-413. ISSN 1610-0379, 1610-0387
Full text not available from this repository. (Request a copy)Abstract
Actinic keratoses (AKs) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guidelines for actinic keratosis and cutaneous squamous cell carcinoma were developed using the highest level of methodology (S3) according to regulations issued by the Association of Scientific Medical Societies in Germany (AWMF). The guidelines are aimed at dermatologists, general practitioners, ENT specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings as well as other medical specialties involved in the diagnosis and treatment of patients with AKs and cSCC. The guidelines are also aimed at affected patients, their relatives, policy makers and insurance funds. In the second part, we will address aspects relating to epidemiology, etiology, surgical and systemic treatment of cSCC, follow-up and disease prevention, and discuss AKs and cSCC in the context of occupational disease regulations.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | NONMELANOMA SKIN-CANCER; RENAL-TRANSPLANT RECIPIENTS; LYMPH-NODE BIOPSY; MEDIATED PHOTODYNAMIC THERAPY; HIGH-RISK FEATURES; NECK DISSECTION; ADJUVANT RADIOTHERAPY; HEAD; ELECTROCHEMOTHERAPY; METASTASIS; |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Strahlentherapie |
| Depositing User: | Petra Gürster |
| Date Deposited: | 08 Apr 2021 06:46 |
| Last Modified: | 08 Apr 2021 06:46 |
| URI: | https://pred.uni-regensburg.de/id/eprint/44768 |
Actions (login required)
 |
View Item |
